Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-27T00:02:47.299Z Has data issue: false hasContentIssue false
  • English
  • Français

Transient Recurrence of Auditory Hallucinations During Acute Dystonia

Published online by Cambridge University Press:  02 January 2018

Leo P. W. Chiu
Leo P. W. Chiu*
Affiliation:
Room 1406A, Sino Centre, 582–592, Nathan Road, Kowloon, Hong Kong
Get access Rights & Permissions [Opens in a new window]

Abstract

Three schizophrenic patients who had transient recurrence of auditory hallucinations during acute dystonia precipitated by neuroleptic medication are reported. If it is accepted that psychotic symptoms result from dopaminergic overactivity, such phenomena suggest that acute dystonia might also have been caused by increased dopaminergic neurotransmission in these cases.

Type
Brief Report
Information
The British Journal of Psychiatry , Volume 155 , Issue 1 , July 1989 , pp. 110 - 113
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Angrist, B. & Sudilovsky, A. (1978) Central nervous system stimulants: historical aspects and clinical effects. In Handbook of Psychopharmacology (eds Iverson L. L., Iverson S. D. & Snyder S. H.), vol. 11, pp. 99–165. New York: Plenum Press.Google Scholar
Borison, R. L., Blowers, A. J. & Diamond, B. I. (1982) New horizons in the treatment of neuropsychiatric disorders. In Tardive Dyskinesia and Related Involuntary Movement Disorders (ed. De Veaugh-Geiss J.), pp. 131–146. Boston: John Wright.Google Scholar
Bowers, M. B. Jr (1973) 5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines. Psychopharmacologia, 28, 309–318.CrossRefGoogle ScholarPubMed
Connell, P. H. (1958) Amphetamine Psychosis (Maudsley monographs). London: Oxford University Press.Google Scholar
Cooklin, R., Sturgeon, D. & Leff, J. (1983) The relationship between auditory hallucinations and spontaneous fluctuations of skin conductance in schizophrenia. British Journal of Psychiatry, 142, 47–52.CrossRefGoogle ScholarPubMed
Crow, T. J. (1987) The dopamine hypothesis survives, but there must be a way ahead. British Journal of Psychiatry, 151, 460–465.Google Scholar
Dinan, T. G. (1987) Calcium-activated potassium conductance: an alternative to the dopamine hypothesis of neuroleptic action? British Journal of Psychiatry, 151, 455–459.CrossRefGoogle Scholar
Fahn, S. & Marsden, C. D. (1987) The treatment of dystonia. In Movement Disorders 2 (eds Marsden C. D. & Fahn S.), pp. 359–382. London: Butterworths.Google Scholar
Fann, W. E. (1966) Use of methylphenidate to counteract acute dystonic effects of phenothiazines. American Journal of Psychiatry, 122, 1293–1294.CrossRefGoogle ScholarPubMed
Fyro, B., Wode-Helgodt, B., Borg, S., et al (1974) The effect of chlorpromazine on homovanillic acid levels in cerebrospinal fluid of schizophrenic patients. Psychopharmacologia, 35, 287–294.Google Scholar
Garver, D. L., Davis, J. M., Dekirmejian, H., et al (1976) Pharmacokinetics of red blood cell phenothiazine and clinical effects: acute dystonic reactions. Archives of General Psychiatry, 33, 862.CrossRefGoogle ScholarPubMed
Grohmann, R., Gunther, W. & Ruther, E. (1983) Adverse effects of psychotropic drugs. In Psychopharmacology 1. Part 2: Clinical Psychopharmacology (eds Hippius H. & Winokur G.), pp. 378–397. Amsterdam: Excerpta Medica.Google Scholar
Harris, P. Q., Brown, S. J., Friedman, M. J., et al (1984) Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics. Biological Psychiatry, 19, 849–860.Google Scholar
Hirsch, S. R. (1982) Medication and physical treatment of schizophrenia. In Handbook of Psychiatry, vol. 3. Psychoses of Uncertain Aetiology (eds Wing J. K. & Wing L.), pp. 74–87. Cambridge: Cambridge University Press.Google Scholar
Hollister, L. E. (1983) Clinical Pharmacology of Psychotherapeutic Drugs (2nd edn), pp. 110–171. New York: Churchill Livingstone.Google Scholar
Iversen, L. L. (1987) Commentary on Dinan's hypothesis. British Journal of Psychiatry, 151, 459–460.Google Scholar
Korczyn, A. D. & Goldberg, G. J. (1972) Intravenous diazepam in drug-induced dystonic reactions. British Journal of Psychiatry, 121, 75–77.CrossRefGoogle ScholarPubMed
Loudon, J. B. (1983) Drug treatments. In Companion to Psychiatric Studies (3rd edn) (eds Kendell R. E. & Zealley A. K.), pp. 603–627. Edinburgh: Churchill Livingstone.Google Scholar
Mackay, A. V. P. (1982) Antischizophrenic drugs. In Drugs in Psychiatric Practice (ed. Tyrer P. J.), pp. 42–81. London: Butterworths.Google Scholar
Randrup, A. & Munkvad, I. (1972) Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain. Orthomolecular Psychiatry, 1, 2–7.Google Scholar
Roos, R. A. C. & Bruyn, G. W. (1986) Symptomatic dystonias. In Handbook of Clinical Neurology, vol. 5 (49): Extrapyramidal Disorders (eds Vinken P. J., Bruyn G. W. & Klawans H. L.), pp. 541–547. Amsterdam: Elsevier Science Publishers.Google Scholar
Roos, R. A. C. & Buruma, O. J. S. (1984) Extrapyramidal side effects of neuroleptic drugs. Journal of Drug Therapy and Research, 9, 82–85.Google Scholar
Sedvall, G., Fyro, B., Nyback, H., et al (1974) Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs. Journal of Psychiatric Research, 11, 75–80.CrossRefGoogle ScholarPubMed
Silverstone, T. & Goodall, E. (1985) How amphetamine works. In Psychopharmacology: Recent Advances and Future Prospects (ed. Iverson S. D.), pp. 315–325. Oxford: Oxford University Press.Google Scholar
Silverstone, T. & Turner, P. (1982) Drug Treatment in Psychiatry, pp. 93–133. London: Routledge & Kegan Paul.Google Scholar
Slade, P. D. (1972) The effects of systemic desensitisation on auditory hallucinations. Behaviour Research and Therapy, 10, 85–91.Google Scholar
Smith, M. J. & Miller, M. M. (1961) Severe extrapyramidal reactions to perphenazine treated with diphenhydramine. New England Journal of Medicine, 264, 396–397.Google Scholar
Swett, C. (1975) Drug-induced dystonia. American Journal of Psychiatry, 132, 532–534.Google ScholarPubMed
Walker, J. I. & Cavenar, J. O. Jr (1983) Hallucinations. In Signs and Symptoms in Psychiatry (eds Cavenar J. O. Jr & Brodie H. K. H.), pp. 433–454. Philadelphia: Lippincott.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.